FDA Inspection 1253253 — Nusayba A. Bagegni, M.D.
The FDA completed an inspection of Nusayba A. Bagegni, M.D. on Oct 28, 2024 in Saint Louis, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 28, 2024
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Saint Louis, MO (United States)
Additional Details
Clinical Investigator (CI)